BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
This company is included in Intelligence Lab

Evaxion Biotech

Evaxion Biotech logo

Website
http://evaxion-biotech.com/
Founded
2008

Technologies

AI Companies (Drug Discovery)

Using cutting-edge immunology, bioinformatics, and machine learning methods, Evaxion Biotech is discovering and developing 'best in class’ vaccines for infectious diseases and cancer at an unprecedented rate. We have constructed a robust product engine for the development of novel vaccines and therapies based on our two platforms, PIONEER and EDEN. Using state of the art in silico tools, the platforms integrate big data, artificial intelligence and supercomputing to predict, rank and optimize epitopes and antigens that elicit a highly protective immune response against cancers and infectious diseases. EDEN enables rapid and accurate discovery of novel antigens that elicit a highly cross-protective immune response in any bacterial pathogen while PIONEER has been constructed to identify the epitopes of mutated proteins that will fire up the body’s natural immune responses to them.

Immunoinformatics Immunotherapy Antigen Discovery Bioinformatics


Articles Mentioning This Company

These 5 Companies Enable Precision Oncology Using AI

Five AI-driven Drug Discovery Companies Enabling Precision Oncology

Oct. 9, 2025     Articles
Artificial Intelligence (AI) is steadily making its presence felt across various sectors, including the pharmaceutical industry. Among the multiple applications of AI in this field, immunotherapy—a treatment method that utilizes the body's immune system to combat diseases, notably cancer—is seeing a significant influence. The integration of AI can potentially enhance …

10 Companies Applying AI for Biologics Discovery

Jan. 26, 2024     Articles
When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery in the first place. Indeed, as it was captured and analyzed in the report The Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D roughly half of more than 300 analyzed …
Danish Biotech Uses AI To Develop Anticancer And Antimicrobial Vaccines

Evaxion Biotech Uses AI To Develop Anticancer And Antimicrobial Vaccines

Aug. 21, 2017     Articles
This is an interview with Niels Iversen Møller, a CEO, and Co-founder of Evaxion Biotech -- an immuno-informatics biotech from Denmark. Evaxion Biotech uses its machine learning-based platform to compare DNAs of tumor cells and DNAs healthy cells and identify mutations that are critical for the disease. This data is …

R&D Platform

We are an AI-immunology platform company using our proprietary artificial intelligence technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop unique immunotherapies for patients.

News

  • 2024-12-13
    Evaxion Biotech Announces Proof-of-Concept for AI-Driven Cancer Vaccines Targeting Endogenous Retrovirus Tumor Antigens
  • 2024-07-16
    Evaxion Biotech Showcases Enhanced AI-Immunology™ Capabilities at ISMB 2024

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.